Speeches, Articles and Testimony

Refine your results

Filtros

Topic

Type

Fecha

Start Date

End Date

Displaying 41 - 60 of 159

Show:

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Sanofi/Maze Therapeutics

Date

20 de Dic de 2023

Matter Number

D09422

Lina M. Khan, Chair;

Rebecca Kelly Slaughter, Commissioner

Text of Statement (126.92 KB)

Letter From Chair Khan to Rep. Tiffany Regarding Merger Challenges

Date

3 de Nov de 2023

Lina M. Khan, Chair

Letter From Chair Khan to Rep. Tiffany Regarding Merger Challenges (253.93 KB)

Appendix A - FTC Merger Enforcement (134.79 KB)

Remarks of Chair Lina M. Khan at Stanford Institute for Economic Policy Research

Date

2 de Nov de 2023

Lina M. Khan, Chair

Remarks of Chair Lina M. Khan at Stanford Institute for Economic Policy Research (230.04 KB)

Remarks of Chair Lina M. Khan at the International Competition Network Conference

Date

18 de Oct de 2023

Lina M. Khan, Chair

Remarks of Chair Lina M. Khan at the International Competition Network Conference (220.95 KB)

Remarks of Chair Lina M. Khan Regarding the White House Announcement of New Actions to Protect Consumers from Hidden Junk Fees

Date

10 de Oct de 2023

Lina M. Khan, Chair

Remarks of Chair Lina M. Khan Regarding the White House Announcement of New Actions to Protect Consumers from Hidden Junk Fees (157.72 KB)

Remarks of Chair Lina M. Khan as Prepared for Delivery at the Fordham 50th Annual Conference on International Antitrust Law & Policy

Date

22 de Sep de 2023

Lina M. Khan, Chair

Remarks of Chair Lina M. Khan as Prepared for Delivery - Fordham 50th Annual Conference on International Antitrust Law & Policy (235.91 KB)

Statement of Chair Lina M. Khan at the September Open Commission Meeting on Brand Drug Manufacturers’ Improper Listing of Patents in the Orange Book

Date

14 de Sep de 2023

Lina M. Khan, Chair

Statement of Chair Lina M. Khan at the September Open Commission Meeting on Brand Drug Manufacturers’ Improper Listing of Patents in the Orange Book (186.42 KB)

Related Releases

FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc

Date

1 de Sep de 2023

Lina M. Khan, Chair;

Alvaro Bedoya, Commissioner;

Rebecca Kelly Slaughter, Commissioner

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc (231.33 KB)

Related Releases

Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition

Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya, in the Matter of EQT Corporation

In the Matter of EQT Corporation

Date

16 de Ago de 2023

Matter Number

2210212

Lina M. Khan, Chair;

Rebecca Kelly Slaughter, Commissioner;

Alvaro Bedoya, Commissioner

Statement of Chair Khan, Joined by Commissioners Slaughter and Bedoya, in In the Matter of EQT Corporation (253.12 KB)

Related Releases

FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal

Letter from Chair Lina M. Khan to Chairman Jim Jordan, House Committee on the Judiciary, Concerning the FTC's Responsiveness to Committee Requests

Letter to Representative Jim Jordan, Chair, House Committee on the Judiciary

Date

11 de Ago de 2023

Lina M. Khan, Chair

Text of the Letter (112.07 KB)

Letter from FTC Chair Lina M. Khan to Chairman Jim Jordan on Committee Harassment of FTC Career Staff

Date

26 de Jul de 2023

Lina M. Khan, Chair

Letter from FTC Chair Lina M. Khan to Chairman Jim Jordan on Committee Harassment of FTC Career Staff (116.19 KB)

Remarks of Chair Lina M. Khan at Economic Club of New York

Date

25 de Jul de 2023

Lina M. Khan, Chair

Remarks of Chair Lina M. Khan at Economic Club of New York (246.18 KB)

Statement of Chair Lina M. Khan Regarding the Policy Statement Concerning Reliance on Prior PBM-Related Advocacy Statements and Reports

Date

20 de Jul de 2023

Lina M. Khan, Chair

Statement of Chair Lina M. Khan Regarding the Policy Statement Concerning Reliance on Prior PBM-Related Advocacy Statements and Reports (145.49 KB)

Related Releases

FTC Votes to Issue Statement Withdrawing Prior Pharmacy Benefit Manager Advocacy

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines

Date

19 de Jul de 2023

Matter Number

P234000

Lina M. Khan, Chair

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines (196.08 KB)

Related Releases

FTC and DOJ Seek Comment on Draft Merger Guidelines

Chair Khan Opening Statement to the United States House of Representatives Committee on the Judiciary Hearing on Oversight of the Federal Trade Commission

Date

13 de Jul de 2023

Lina M. Khan, Chair

Chair Khan Opening Statement to the United States House of Representatives Committee on the Judiciary Hearing on Oversight of the Federal Trade Commission (98.32 KB)

Related Releases

FTC Provides Testimony Before the House Judiciary Committee at Oversight Hearing

Testimony of the Federal Trade Commission Before the House Committee on the Judiciary Concerning Oversight of the FTC

Before the House Committee on the Judiciary

Washington, D.C.

Congressional Session

117th Congress

Date

13 de Jul de 2023

Matter Number

P210100

Lina M. Khan, Chair

Testimony of the Federal Trade Commission Before the House Committee of the Judiciary Concerning Oversight of the FTC (1.5 MB)

Related Releases

FTC Provides Testimony Before the House Judiciary Committee at Oversight Hearing

Letter from Chair Lina M. Khan to Chairman Jim Jordan, House Committee on the Judiciary, Concerning Committee Requests for Testimony from Multiple FTC Staff

Concerning Committee Requests for Testimony from Multiple FTC Staff

Date

7 de Jul de 2023

Lina M. Khan, Chair

Text of the Letter (164.13 KB)

Statement of Chair Lina M. Khan in the Matter of Smoke Away

Date

30 de Jun de 2023

Lina M. Khan, Chair

Statement of Chair Lina M. Khan in the Matter of Smoke Away (189.56 KB)

Related Releases

FTC Acts to Stop Owner, Marketers of ‘Smoke Away’ from Deceptively Claiming Products Enable Users to Quit Smoking

Statement of Chair Lina M. Khan Joined by Commissioners Slaughter and Bedoya Regarding Proposed Amendments to the Premerger Notification Form and the Hart-Scott-Rodino Rules

Date

27 de Jun de 2023

Lina M. Khan, Chair;

Rebecca Kelly Slaughter, Commissioner;

Alvaro Bedoya, Commissioner

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding Proposed Amendments to the Premerger Notification Form and the Hart-Scott-Rodino Rules (130.41 KB)

Related Releases

FTC and DOJ Propose Changes to HSR Form for More Effective, Efficient Merger Review

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of Publishers Clearing House

Date

26 de Jun de 2023

Matter Number

182 3145

Lina M. Khan, Chair;

Rebecca Kelly Slaughter, Commissioner;

Alvaro Bedoya, Commissioner

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of Publishers Clearing House (125.76 KB)

Related Releases

FTC Takes Action Against Publishers Clearing House for Misleading Consumers About Sweepstakes Entries

Displaying 41 - 60 of 159

Join us at the FTC!

View our open positions

Speeches, Articles and Testimony by Lina M. Khan

Refine your results

Refine your results